In addition to NMDA receptors, altered AMPA receptor subunit composition has been suggested as a potential mechanism underlying enhanced early-phase LTP in mouse models of CDD, where higher levels of CP GluA2-lacking AMPA receptors were observed at baseline [13]. Here, CP is linked to craniodiaphyseal dysplasia.